Baltimore, Maryland–(Newsfile Corp. – June 7, 2021) – The Board and Management of Flavocure Biotech, Inc. (“Flavocure”) a
BALTIMORE, MARYLAND, August 27, 2020 – For Immediate Release – Flavocure Biotech, Inc. (“Flavocure”) a drug discovery and development
Microglia-mediated neuroinflammation plays a pivotal role in the initiation and propagation of pathological markers of neurodegenerative disorders including Alzheimer’s disease
Abstract Clinical cancer treatment modalities include radiation as one of the first-line therapies used for treating almost two-thirds of cancer
Get all latest news from Flavocure Biotech
